Compare Marvell Technology Inc (MRVL) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs 10X Genomics Inc — how do they compare? Marvell Technology Inc trades at $209.85 (market cap $171.11B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Marvell Technology Inc is far larger — about 31.2× 10X Genomics Inc's market cap, and Marvell Technology Inc pays a 0.12% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| MRVL | TXG | |
|---|---|---|
Market Cap | $171.11B | $5.48B |
Sector | Technology | Health |
52-Week High | $316.43 | $45.80 |
52-Week Low | $62.31 | $11.34 |
Enterprise Value | $172.55B | $5.02B |
Dividend Yield | 0.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
